Several studies indicate that the hypermethylation of SALL1 and SALL3 promoters correlates with poor outcomes and recurrence in head and neck squamous cell carcinoma (HNSCC) [95,96,97]. This evidence concerns the gene SALL1 and head and neck squamous cell carcinoma.